Table 2 Select Baseline Demographic and Baseline Disease Characteristics of Responders and Non-Responders (Observed Cases)
Baseline Characteristic* | Week 24 | Week 128 | ||||
|---|---|---|---|---|---|---|
Responders (n = 66) | Non-responders (n = 175) | p value** | Responders (n = 91) | Non-responders (n = 128) | p value** | |
Age, years | 45.4 ± 11.8 | 49.2 ± 11.7 | 0.024 | 45.7 ± 11.8 | 50.1 ± 11.8 | 0.008 |
Men, n (%) | 13 (20) | 16 (9) | 15 (17) | 13 (10) | ||
Women, n (%) | 53 (80) | 159 (91) | 0.025 | 76 (84) | 115 (90) | 0.167 |
Race, n (%) | ||||||
White | 34 (52) | 77 (44) | 0.622 | 46 (51) | 57 (45) | 0.015 |
Mestizo | 15 (23) | 38 (22) | 25 (28) | 23 (18) | ||
African-Latin American | 7 (11) | 27 (15) | 13 (14) | 18 (14) | ||
Other | 10 (15) | 33 (19) | 7 (8) | 30 (23) | ||
BMI, kg/m2 | 26.6 ± 5.3 | 26.3 ± 4.8 | 0.669 | 26.3 ± 4.4 | 26.4 ± 5.2 | 0.860 |
CRP, mg/L | 19.5 ± 25.9 | 21.8 ± 25.4 | 0.521 | 22.5 ± 26.8 | 21.1 ± 26.1 | 0.707 |
ESR, mm/h | 37.3 ± 11.2 | 44.3 ± 17.4 | 0.003 | 39.6 ± 13.8 | 43.1 ± 16.5 | 0.104 |
Disease duration, years | 8.2 ± 7.1 | 7.4 ± 6.5 | 0.428 | 7.4 ± 6.4 | 8.0 ± 7.0 | 0.534 |
RF positive, n (%) | 55 (83) | 155 (89) | 0.279 | 73 (80) | 117 (91) | 0.016 |
HAQ total score | 1.3 ± 0.7 | 1.7 ± 0.7 | 0.001 | 1.5 ± 0.7 | 1.6 ± 0.7 | 0.376 |
VAS Pain, mm | 60.0 ± 23.6 | 66.1 ± 20.3 | 0.047 | 61.6 ± 25.7 | 66.0 ± 18.2 | 0.141 |
PGA | 6.5 ± 1.9 | 7.2 ± 1.9 | 0.013 | 6.7 ± 2.2 | 7.1 ± 1.8 | 0.122 |
SF-36 Mental Health Scale | 41.0 ± 11.3 | 40.3 ± 11.0 | 0.665 | 41.5 ± 10.8 | 39.6 ± 11.3 | 0.223 |
Prorated number of tender joints | 22.2 ± 10.9 | 26.0 ± 11.9 | 0.024 | 24.6 ± 11.1 | 25.5 ± 12.4 | 0.600 |
Prorated number of swollen joints | 17.6 ± 7.9 | 18.4 ± 8.6 | 0.504 | 19.9 ± 8.9 | 17.3 ± 8.2 | 0.029 |